Skip to main content
Frontiers in Immunology logoLink to Frontiers in Immunology
. 2025 Jul 9;16:1650718. doi: 10.3389/fimmu.2025.1650718

Correction: Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics

Xiaoting Lin 1,2,3,4, Peng Liu 1,2,3,4, Guoyan Qi 1,2,3,4,*
PMCID: PMC12284366  PMID: 40703512

In the published article, there was an error regarding the affiliations for Guoyan Qi. As well as having affiliations 1,3,4, she should also have “2 Treatment Center of Myasthenia Gravis, People’s Hospital of Shijiazhuang, Shijiazhuang, Hebei, China”. Also, the order of authors in the author list of the published paper was erroneously given as:

“Xiaoting Lin, Guoyan Qi, Peng Liu”

The correct author list reads:

“Xiaoting Lin, Peng Liu, Guoyan Qi”

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Immunology are provided here courtesy of Frontiers Media SA

RESOURCES